Takotsubo cardiomyopathy concurrent with hyperthyroidism following COVID-19—a case report and literature review - Takeaways - MDSpire

Takotsubo cardiomyopathy concurrent with hyperthyroidism following COVID-19—a case report and literature review

  • By

  • Liya Lin

  • Shanshan Liu

  • Yi Fang

  • Qijing Zhou

  • Minyue Jia

  • Hanxiao Yu

  • Kai Cheok

  • Xuehua Zhang

  • Lingxia Ye

  • Xiaoxiao Song

  • July 8, 2026

  • 0 min

Share

  • 1

    A 21-year-old male developed Takotsubo cardiomyopathy after SARS-CoV-2 infection, presenting with tachycardia and ST-segment elevation.

  • 2

    Thyrotoxicosis was confirmed through biochemical and imaging studies, indicating a potential link between COVID-19 and exacerbated autoimmune thyroid dysfunction.

  • 3

    Emergency coronary angiography ruled out myocardial infarction, highlighting the need for differential diagnosis in similar cases.

  • 4

    Treatment with methimazole and beta-blockers led to resolution of cardiac dysfunction and normalization of thyroid function.

  • 5

    The case suggests a potential interplay between COVID-19, hyperthyroidism, and Takotsubo syndrome, warranting further investigation.

Original Source(s)

Takotsubo cardiomyopathy concurrent with hyperthyroidism following COVID-19—a case report and literature review

  • by Liya Lin, Shanshan Liu, Yi Fang, Qijing Zhou, Minyue Jia, Hanxiao Yu, Kai Cheok, Xuehua Zhang, Lingxia Ye, Xiaoxiao Song

  • July 8, 2026

Related Content

Global information-seeking behavior of air pollution and cardiovascular disease: insights from google trends analysis

Sex-based disparities in cardiovascular outcomes: real-world evidence following chimeric antigen receptor T-cell therapy

Beyond adrenal suppression: a comprehensive post-marketing safety profile of etomidate from real world data